# ChemoCentryx, Inc.

ChemoCentryx, Inc. is a company headquartered in San Carlos, CA, United States.

## Company overview

- **Legal name:** ChemoCentryx, Inc.
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** San Carlos, CA, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001340652

## About

ChemoCentryx, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001340652, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2022-03-01, it reported annual revenue of USD 32,224,000; net income of USD -131,755,000; total assets of USD 425,652,000 for the fiscal period ended 2021-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2021 (period ended 2021-12-31)

- **Revenue:** $32.2M (USD 32,224,000)
- **Net income:** -$131.8M (USD -131,755,000)
- **Total assets:** $425.7M (USD 425,652,000)
- **Cash and equivalents:** $50.0M (USD 49,978,000)
- **Operating cash flow:** -$75.6M (USD -75,621,000)

### FY2020 (period ended 2020-12-31)

- **Revenue:** $0 (USD 0)
- **Net income:** -$55.4M (USD -55,356,000)
- **Total assets:** $518.9M (USD 518,899,000)
- **Cash and equivalents:** $32.3M (USD 32,297,000)
- **Operating cash flow:** -$81.1M (USD -81,143,000)

### FY2019 (period ended 2019-12-31)

- **Revenue:** $36.1M (USD 36,128,000)
- **Net income:** -$55.5M (USD -55,489,000)
- **Total assets:** $209.1M (USD 209,083,000)
- **Cash and equivalents:** $39.2M (USD 39,179,000)
- **Operating cash flow:** -$70.1M (USD -70,123,000)

### FY2018 (period ended 2018-12-31)

- **Revenue:** $42.9M (USD 42,875,000)
- **Net income:** -$38.0M (USD -37,966,000)
- **Total assets:** $183.3M (USD 183,310,000)
- **Cash and equivalents:** $28.1M (USD 28,088,000)
- **Operating cash flow:** $16.4M (USD 16,436,000)

## Recent SEC filings

- Form 8-K — filed 2022-10-20 — period 2022-10-20 — 8-K
- Form 8-K — filed 2022-10-18 — period 2022-10-18 — 8-K
- Form 8-K — filed 2022-09-20 — period 2022-09-19 — 8-K
- Form 10-Q — filed 2022-08-08 — period 2022-06-30 — 10-Q
- Form 8-K — filed 2022-08-04 — period 2022-08-03 — 8-K
- Form 8-K — filed 2022-07-05 — period 2022-06-28 — 8-K
- Form 8-K — filed 2022-06-09 — period 2022-06-06 — 8-K
- Form 8-K — filed 2022-06-01 — period 2022-05-26 — 8-K
- Form 10-Q — filed 2022-05-10 — period 2022-03-31 — 10-Q
- Form 8-K — filed 2022-05-05 — period 2022-05-05 — 8-K
- Form 8-K — filed 2022-05-03 — period 2022-05-03 — 8-K
- Form DEF 14A — filed 2022-04-05 — period 2022-05-26 — DEF 14A

---

Updated: 2026-10-23T20:06:36Z

Canonical page: https://altss.com/profile/chemocentryx-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology